| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 151, 335-342, Copyright © 1997 by American Society for Investigative Pathology
REGULAR ARTICLES |
CA Werner, H Dohner, S Joos, LH Trumper, M Baudis, TF Barth, G Ott, P Moller, P Lichter and M Bentz
Medizinische Klinik und Poliklinik V, Universitat Heidelberg, Germany.
Gene amplification is one of the molecular mechanisms resulting in the up-regulation of gene expression. In non-Hodgkin's lymphomas, such gene amplifications have been identified rarely. Using comparative genomic hybridization, a technique that has proven to be very sensitive for the detection of high-level DNA amplifications, we analyzed 108 cases of B- cell neoplasms (42 chronic B-cell leukemias, 5 mantle cell lymphomas, and 61 aggressive B-cell lymphomas). Twenty-four high-level amplifications were identified in 13% of the patients and mapped to 15 different genomic regions. Regions most frequently amplified were bands Xq26-28, 2p23-24, and 2p14-16 as well as 18q21 (three times each). Amplification of several proto-oncogenes and a cell cycle control gene (N-MYC (two cases), BCL2, CCND2, and GLI) located within the amplified regions was demonstrated by Southern blot analysis or fluorescence in situ hybridization to interphase nuclei of tumor cells. These data demonstrate that gene amplifications in B-cell neoplasms are much more frequent than previously assumed. The identification of highly amplified DNA regions and genes included in the amplicons provides important information for further analyses of genetic events involved in lymphomagenesis.
This article has been cited by other articles:
![]() |
L. S. Reinert, B. Shi, S. Nandi, K. Mazan-Mamczarz, M. Vitolo, K. E. Bachman, H. He, and R. B. Gartenhaus MCT-1 Protein Interacts with the Cap Complex and Modulates Messenger RNA Translational Profiles. Cancer Res., September 15, 2006; 66(18): 8994 - 9001. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Rubio-Moscardo, J. Climent, R. Siebert, M. A. Piris, J. I. Martin-Subero, I. Nielander, J. Garcia-Conde, M. J. S. Dyer, M. J. Terol, D. Pinkel, et al. Mantle-cell lymphoma genotypes identified with CGH to BAC microarrays define a leukemic subgroup of disease and predict patient outcome Blood, June 1, 2005; 105(11): 4445 - 4454. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dahlen, C. D. M. Fletcher, F. Mertens, J. A. Fletcher, A. R. Perez-Atayde, M. J. Hicks, M. Debiec-Rychter, R. Sciot, J. Wejde, R. Wedin, et al. Activation of the GLI Oncogene through Fusion with the {beta}-Actin Gene (ACTB) in a Group of Distinctive Pericytic Neoplasms: Pericytoma with t(7;12) Am. J. Pathol., May 1, 2004; 164(5): 1645 - 1653. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Schwaenen, M. Nessling, S. Wessendorf, T. Salvi, G. Wrobel, B. Radlwimmer, H. A. Kestler, C. Haslinger, S. Stilgenbauer, H. Dohner, et al. Automated array-based genomic profiling in chronic lymphocytic leukemia: Development of a clinical tool and discovery of recurrent genomic alterations PNAS, January 27, 2004; 101(4): 1039 - 1044. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sanchez-Izquierdo, G. Buchonnet, R. Siebert, R. D. Gascoyne, J. Climent, L. Karran, M. Marin, D. Blesa, D. Horsman, A. Rosenwald, et al. MALT1 is deregulated by both chromosomal translocation and amplification in B-cell non-Hodgkin lymphoma Blood, June 1, 2003; 101(11): 4539 - 4546. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Hu, J. M. Bonifas, G. Aragon, L. Kopelovich, Y. Liang, S. Ohta, M. A. Israel, D. R. Bickers, M. Aszterbaum, and E. H. Epstein Jr. Evidence for Lack of Enhanced Hedgehog Target Gene Expression in Common Extracutaneous Tumors Cancer Res., March 1, 2003; 63(5): 923 - 928. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Korz, A. Pscherer, A. Benner, D. Mertens, C. Schaffner, E. Leupolt, H. Dohner, S. Stilgenbauer, and P. Lichter Evidence for distinct pathomechanisms in B-cell chronic lymphocytic leukemia and mantle cell lymphoma by quantitative expression analysis of cell cycle and apoptosis-associated genes Blood, May 29, 2002; 99(12): 4554 - 4561. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Hernandez, J. L. Garcia, N. C. Gutierrez, M. Mollejo, J. A. Martinez-Climent, T. Flores, M. B. Gonzalez, M. A. Piris, and J. F. San Miguel Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics Am. J. Pathol., May 1, 2001; 158(5): 1843 - 1850. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. Rickert, B. Dockhorn-Dworniczak, R. Simon, and W. Paulus Chromosomal Imbalances in Primary Lymphomas of the Central Nervous System Am. J. Pathol., November 1, 1999; 155(5): 1445 - 1451. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Bea, M. Ribas, J. M. Hernandez, F. Bosch, M. Pinyol, L. Hernandez, J. L. Garcia, T. Flores, M. Gonzalez, A. Lopez-Guillermo, et al. Increased Number of Chromosomal Imbalances and High-Level DNA Amplifications in Mantle Cell Lymphoma Are Associated With Blastoid Variants Blood, June 15, 1999; 93(12): 4365 - 4374. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. F.E. Barth, H. Dohner, C. A. Werner, S. Stilgenbauer, M. Schlotter, M. Pawlita, P. Lichter, P. Moller, and M. Bentz Characteristic Pattern of Chromosomal Gains and Losses in Primary Large B-Cell Lymphomas of the Gastrointestinal Tract Blood, June 1, 1998; 91(11): 4321 - 4330. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |